You Searched For "antibody drug" and got 20 results
Sort By:
4 mins read
Scientists say weight-loss drugs could protect our brains from dementia. Early results suggest they're onto something.
Patients with Alzheimer's who took a GLP-1 drug improved their memory scores and lost less of their…
Hilary Brueck
2 mins read
A supplement derived from cow's milk is taking over TikTok, but health experts say its benefits aren't clear
Colostrum has gained popularity on TikTok for reducing bloating and improving gut health. But there…
Alex Bitter
1 min read
A new Ozempic rival helps patients lose fat, but keep their muscle the holy grail for a weight-loss drug
The Ozempic rival helped people lose weight while keeping more of their muscles intact. In a trial,…
Hilary Brueck
5 mins read
How to make money from medical research and donations
You can make good money from donating plasma or sperm on a regular basis. Other donations and scien…
Hilary Brueck
2 mins read
IIT Madras team develops novel database on Covid antibodies
Researchers at the Indian Institute of Technology (IIT) Madras have developed an online open-source…
2 mins read
Worried if your cold is Covid? New ultra-thin sensor to help detect Covid & flu in 10 secs
Worried whether your cough, sore throat and congestion is Covid-19 or flu? A new ultra-thin sensor …
2 mins read
AstraZeneca's antibody cocktail can prevent, treat Covid-19
The drug, AZD7442, is a combination of two antibodies -- tixagevimab (AZD8895) and cilgavimab (A…
3 mins read
An experimental drug just showed it can help slow Alzheimer's, offering new hope for patients and a major boost to pharma giant Eli Lilly
In a late-stage trial, Eli Lilly's experimental Alzheimer's treatment slowed the rate of cognitive …
Yeji Jesse Lee
3 mins read
Roche India rolls out first batch of its antibody drugs Casirivimab and Imdevimab against COVID-19
Roche India on Monday announced the rollout of its first batch of the antibody cocktail (Casirivima…
2 mins read
AstraZeneca says its COVID-19 drug cuts the risk of severe disease in half. It's the first antibody cocktail shown to both prevent and treat the disease in late-stage trials.
AstraZeneca has already requested FDA authorization for its injection, AZD7442, to prevent COVID-19…
Dr. Catherine Schuster-Bruce
2 mins read
Lilly paused it coronavirus antibody drug trial
These are Business Insider's biggest healthcare stories for October 14.
Lydia Ramsey Pflanzer
2 mins read
The FDA just authorized Eli Lilly's antibody treatment for emergency use to treat the coronavirus
The company's antibody treatment is similar to the one President Donald Trump received in the hospi…
Graham Rapier,Isabella Jibilian
2 mins read
A man's mysterious immune reaction ruined his plan to propose to his girlfriend on vacation as he developed uncontrollable rage and tremors
Mike spent his vacation boiling with rage due to a molecule blocking receptors that are vital for m…
Andrea Michelson
1 min read
Eli Lilly just paused its COVID-19 antibody drug trial over safety concerns
Lilly paused the study after an independent board raised safety concerns and recommended the trial …
Graham Rapier
3 mins read
Trump calls for the FDA to approve one of the COVID-19 treatments he got
These are Business Insider's biggest healthcare stories for October 8.
Lydia Ramsey Pflanzer
2 mins read
Artificial intelligence has helped in developing a drug that can cure COVID-19 patients
The preclinical stage is an important part of drug development and is the stage just before huma…
2 mins read
A new COVID shot is more effective against current variants and may have fewer side effects
The FDA approved an updated COVID-19 vaccine from Novavax. The vaccine is more effective at protect…
Kate Hull
3 mins read
I have an insulin allergy, which makes managing my type 1 diabetes extremely difficult
Having type 1 diabetes and insulin allergy makes things extremely difficult. I spent 43 days in the…
Lauren Crosby Medlicott
3 mins read
Blood pressure drug ineffective in treating even mild Covid-19 cases, as per 'real world' data from India
A drug used to treat high blood pressure was found to be ineffective in treating even mild COVID-19…
PTI
2 mins read
The US will spend $375 million on 300,000 vials of Eli Lilly's experimental COVID-19 antibody therapy — if the FDA approves it
Eli Lilly said its bamlanivimab antibody therapy, which is awaiting FDA approval, could treat "high…